Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery

Canadian Journal of Cardiology

Volumn 26, Issue 3, 2010, Pages 151-154

  Imran, Syed Ali ^a   Ransom, Thomas P P ^a   Buth, Karen J ^a   Clayton, Dale ^a   Al Shehri, Bandar ^a   Ur, Ehud ^a   Ali, Imtiaz S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Admission glucose; Bypass surgery; Diabetes; Outcome

Indexed keywords

INOTROPIC AGENT;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CORONARY ARTERY BYPASS GRAFT; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; PROGNOSIS; STROKE; WOUND INFECTION;

EID: 77950554490     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70357-3     Document Type: Article

References (13)

1. Port SC, Boyle NG, Hsueh WA, Quinones MJ, Jenrich RI, Goodarzi MO. The predictive role of blood glucose for mortality in subjects with cardiovascular disease. Am J Epidemiol 2006;163:342-351 (Pubitemid 43238428)
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773-778 (Pubitemid 30128815)
3. Foo K, Cooper J, Deaner A, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003;89:512-516 (Pubitemid 36520800)
4. Bhadriraju S, Ray K, DeFranco A, et al. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 Trial. Am J Cardiol 2006;97:1573-1577 (Pubitemid 43737031)
5. Timmer JR, van der Horst IC, Ottervanger JP, et al; Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399-404.
6. Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7. (Pubitemid 36044395)
7. Gandhi G, Nuttall G, Abel M, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005;80:862-866 (Pubitemid 40911459)
8. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144.e1-8 (Pubitemid 40169564)
9. Fish LH, Weaver TW, Moore Al, Steel LG. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am J Cardiol 2003;92:74-76
10. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-1502 (Pubitemid 38420177)
11. Fortescue E, Kahn K, Bates D. Development and validation of a clinical prediction rule for major adverse outcomes in coronary bypass grafting. Am J Cardiol 2001;88:1251-1258 (Pubitemid 33132093)
12. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: An independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 2001;24:1634-1639 (Pubitemid 33716462)
13. Schmeltz LR, Desantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007;30:823-828 (Pubitemid 46556574)